In metastatic melanoma, the P-T38-activated fraction of c-ETS-1, by competing with c-ETS-1 for binding to DNA, may increase AP-1-driven transcription of those targets, such as miR-222, containing ETS-1 and AP-1 binding sites in close proximity on their promoters. The gene discussed is JUN; the disease is metastatic melanoma.